Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
PRRT2 encodes a transmembrane protein containing a proline-rich domain in its N-terminal half.
Showing 10 out of 28 products:
Results identified PRRT2 and DAB2IP (zeige DAB2IP Antikörper) to be frequently mutated in all different cancer cell line types. Further analysis showed that both genes were also frequently mutated in colorectal and endometrial cancer patient samples. Functional studies revealed PRRT2 to be implicated in cellular proliferation and migration with the truncated microsatellite instability-derived PRRT2 form promoting both processes.
the expression level of PRRT2 was much higher in the human brain than in other human tissues, thus providing experimental evidence for a potential relationship between PRRT2 and neurogenesis. To the best of our knowledge, this study is the first to report the expression pattern of PRRT2 in human tissues.
PRRT2 mutations have roles in neuronal dysfunction and neurodevelopmental defects
The cases reported here constitute the first genetic-confirmed series of paroxysmal kinesigenic dyskinesia (PKD (zeige PRKD1 Antikörper)) in Hong Kong. The PRRT2 c.649dupC screening is recommened for all patients with all forms of PKD (zeige PRKD1 Antikörper).
Data show that proline-rich transmembrane protein 2 (PRRT2) is decreased in glioma and is targeted by microRNA miR (zeige MLXIP Antikörper)-30a-5p.
These findings indicate a novel role for zinc regulation in the PKCalpha (zeige PKCa Antikörper)/beta-catenin (zeige CTNNB1 Antikörper) pathway and explain an important mechanism for controlling of stem cell program in lung cancer cells.
PRRT2 mutations most likely not associated with benign epilepsy with centrotemporal spikes in Chinese mainland population.
Exome sequencing was conducted and a duplication mutation c.649dupC (p.R217Pfs*8) in the proline-rich transmembrane protein 2 gene (PRRT2) was identified in patients with febrile seizures.
In this study, 20 probands with BPEI were negative for family history of BPEI and negative for PRRT2 mutation.
a novel intronic PRRT2 mutation causes paroxysmal kinesigenic dyskinesia with infantile convulsions
Study describes the phenotype of KO mice for PRRT2 and shows that its loss-of-function recapitulates the human phenotype in terms of episodic disturbances in motor coordination and paroxysmal dyskinesias, suggesting that PRRT2 plays a critical role in the development of cortical connectivity and functional stability of neuronal networks.
PRRT2 interacts with the Src (zeige SRC Antikörper) homology 3 domain-bearing protein Intersectin 1 (zeige ITSN1 Antikörper), an intracellular protein (zeige CKAP2 Antikörper) involved in synaptic vesicle cycling.
Mutants associated with paroxysmal kinesigenic dyskinesia with infantile convulsions C lead to dramatically reduced PRRT2 levels.
This gene encodes a transmembrane protein containing a proline-rich domain in its N-terminal half. Studies in mice suggest that it is predominantly expressed in brain and spinal cord in embryonic and postnatal stages. Mutations in this gene are associated with episodic kinesigenic dyskinesia-1. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
dispanin subfamily B member 3
, interferon induced transmembrane protein domain containing 1